Compound Profiles
CJC-1295 with DAC
Long-Acting Growth Hormone Releasing Hormone Analog | Extended Release
DAC binds to albumin, extending half-life to 6-8 days and providing continuous GHRH receptor stimulation for sustained GH/IGF-1 elevation..
GHRP-6
Growth Hormone Releasing Peptide-6 | Hexapeptide GHS
GHRP-6 binds to the growth hormone secretagogue receptor (GHS-R1a), the same receptor activated by ghrelin. This initiates a signaling cascade in the hypothalamus and pituitary gland, triggering a rapid pulse of natural GH secretion.
Combined Organ Load
Shared Safety Flags
Frequently Asked Questions
Can I take CJC-1295 with DAC with GHRP-6?
Yes, but with caution. GHRP pulse effects diminished with continuous GH elevation. Regular monitoring is advised.
Is CJC-1295 with DAC and GHRP-6 safe together?
Based on documented research, this combination is considered monitor. However, shared safety flags include: carcinogenic risk, insulin disrupting. Monitor accordingly.
What are the interactions between CJC-1295 with DAC and GHRP-6?
GHRP pulse effects diminished with continuous GH elevation. This assessment has 90% confidence and is based on documented research data.
How should I time CJC-1295 with DAC and GHRP-6?
CJC-1295 with DAC has a half-life of 6-8 days and GHRP-6 has a half-life of 15-60 minutes. No specific timing requirements identified for this combination, but separating administration can help monitor individual effects.
This interaction analysis is compiled from research literature and pharmacological mechanism data. Always consult a healthcare professional before combining compounds.